Also trades as: NAMS (NASDAQ) · $vol 30M
NAMSW NASDAQ
NewAmsterdam Pharma Company N.V.
1W: +11.0%
1M: -23.4%
3M: -46.0%
YTD: -45.2%
1Y: -26.1%
3Y: +542.1%
5Y: +1542.9%
$12.70
+0.05 (+0.40%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$7M
Revenue
-88.9% YoY
$-260M
Net Income
-56.6% YoY
$-144M
Free Cash Flow
-15.6% YoY
100.0%
Gross Margin
-1752.6%
Op. Margin
-1732.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-36.8%
ROA-34.2%
ROIC8216.2%
Valuation
P/E-10.6
P/B4.5
EV/EBITDA-7.9
Leverage
Debt/Equity0.00
Current Ratio9.03
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z19.73
Beneish M-4.66